271 related articles for article (PubMed ID: 28530237)
1. Anti-platelet factor 4/polyanion antibodies mediate a new mechanism of autoimmunity.
Nguyen TH; Medvedev N; Delcea M; Greinacher A
Nat Commun; 2017 May; 8():14945. PubMed ID: 28530237
[TBL] [Abstract][Full Text] [Related]
2. Distinct Binding Characteristics of Pathogenic Anti-Platelet Factor-4/Polyanion Antibodies to Antigens Coated on Different Substrates: A Perspective on Clinical Application.
Nguyen TH; Greinacher A
ACS Nano; 2018 Dec; 12(12):12030-12041. PubMed ID: 30540167
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune heparin-induced thrombocytopenia.
Greinacher A; Selleng K; Warkentin TE
J Thromb Haemost; 2017 Nov; 15(11):2099-2114. PubMed ID: 28846826
[TBL] [Abstract][Full Text] [Related]
4. Complex formation with nucleic acids and aptamers alters the antigenic properties of platelet factor 4.
Jaax ME; Krauel K; Marschall T; Brandt S; Gansler J; Fürll B; Appel B; Fischer S; Block S; Helm CA; Müller S; Preissner KT; Greinacher A
Blood; 2013 Jul; 122(2):272-81. PubMed ID: 23673861
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of the conformational changes in platelet factor 4 induced by polyanions: towards in vitro prediction of antigenicity.
Brandt S; Krauel K; Gottschalk KE; Renné T; Helm CA; Greinacher A; Block S
Thromb Haemost; 2014 Jul; 112(1):53-64. PubMed ID: 24671506
[TBL] [Abstract][Full Text] [Related]
6. Cleavage of anti-PF4/heparin IgG by a bacterial protease and potential benefit in heparin-induced thrombocytopenia.
Kizlik-Masson C; Deveuve Q; Zhou Y; Vayne C; Thibault G; McKenzie SE; Pouplard C; Loyau S; Gruel Y; Rollin J
Blood; 2019 May; 133(22):2427-2435. PubMed ID: 30917957
[TBL] [Abstract][Full Text] [Related]
7. Platelet factor 4 binds to bacteria, [corrected] inducing antibodies cross-reacting with the major antigen in heparin-induced thrombocytopenia.
Krauel K; Pötschke C; Weber C; Kessler W; Fürll B; Ittermann T; Maier S; Hammerschmidt S; Bröker BM; Greinacher A
Blood; 2011 Jan; 117(4):1370-8. PubMed ID: 20959601
[TBL] [Abstract][Full Text] [Related]
8. Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia.
Prechel MM; Jeske WP; Walenga JM
Thromb Res; 2010 Apr; 125(4):e143-8. PubMed ID: 19931120
[TBL] [Abstract][Full Text] [Related]
9. Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies.
Greinacher A; Gopinadhan M; Günther JU; Omer-Adam MA; Strobel U; Warkentin TE; Papastavrou G; Weitschies W; Helm CA
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2386-93. PubMed ID: 16873726
[TBL] [Abstract][Full Text] [Related]
10. Platelets kill bacteria by bridging innate and adaptive immunity via platelet factor 4 and FcγRIIA.
Palankar R; Kohler TP; Krauel K; Wesche J; Hammerschmidt S; Greinacher A
J Thromb Haemost; 2018 Jun; 16(6):1187-1197. PubMed ID: 29350833
[TBL] [Abstract][Full Text] [Related]
11. Heparin-induced thrombocytopenia: frequency and pathogenesis.
Greinacher A
Pathophysiol Haemost Thromb; 2006; 35(1-2):37-45. PubMed ID: 16855345
[TBL] [Abstract][Full Text] [Related]
12. Polyphosphates form antigenic complexes with platelet factor 4 (PF4) and enhance PF4-binding to bacteria.
Brandt S; Krauel K; Jaax M; Renné T; Helm CA; Hammerschmidt S; Delcea M; Greinacher A
Thromb Haemost; 2015 Nov; 114(6):1189-98. PubMed ID: 26225544
[TBL] [Abstract][Full Text] [Related]
13. Polyphosphate/platelet factor 4 complexes can mediate heparin-independent platelet activation in heparin-induced thrombocytopenia.
Cines DB; Yarovoi SV; Zaitsev SV; Lebedeva T; Rauova L; Poncz M; Arepally GM; Khandelwal S; Stepanova V; Rux AH; Cuker A; Guo C; Ocariza LM; Travers RJ; Smith SA; Kim H; Morrissey JH; Conway EM
Blood Adv; 2016 Nov; 1(1):62-74. PubMed ID: 29296696
[TBL] [Abstract][Full Text] [Related]
14. Effect of pH and ionic strength on the binding strength of anti-PF4/polyanion antibodies.
Nguyen TH; Greinacher A
Eur Biophys J; 2017 Dec; 46(8):795-801. PubMed ID: 28712066
[TBL] [Abstract][Full Text] [Related]
15. Platelet factor 4 triggers thrombo-inflammation by bridging innate and adaptive immunity.
Greinacher A; Warkentin TE
Int J Lab Hematol; 2023 Jun; 45 Suppl 2():11-22. PubMed ID: 37150909
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous binding of heparin and platelet factor-4 to platelets: further insights into the mechanism of heparin-induced thrombocytopenia.
Horne MK; Hutchison KJ
Am J Hematol; 1998 May; 58(1):24-30. PubMed ID: 9590145
[TBL] [Abstract][Full Text] [Related]
17. The immunology of PF4 polyanion interactions.
Ngo ATP; Bochenek V; Gollomp K
Curr Opin Hematol; 2023 Nov; 30(6):219-229. PubMed ID: 37603711
[TBL] [Abstract][Full Text] [Related]
18. Biophysical tools to assess the interaction of PF4 with polyanions.
Delcea M; Greinacher A
Thromb Haemost; 2016 Oct; 116(5):783-791. PubMed ID: 27658429
[TBL] [Abstract][Full Text] [Related]
19. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.
Visentin GP; Ford SE; Scott JP; Aster RH
J Clin Invest; 1994 Jan; 93(1):81-8. PubMed ID: 8282825
[TBL] [Abstract][Full Text] [Related]
20. Activated platelets kill Staphylococcus aureus, but not Streptococcus pneumoniae-The role of FcγRIIa and platelet factor 4/heparinantibodies.
Wolff M; Handtke S; Palankar R; Wesche J; Kohler TP; Kohler C; Gruel Y; Hammerschmidt S; Greinacher A
J Thromb Haemost; 2020 Jun; 18(6):1459-1468. PubMed ID: 32237268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
